Presentation is loading. Please wait.

Presentation is loading. Please wait.

The antimicrobial protein short palate, lung, and nasal epithelium clone 1 (SPLUNC1) is differentially modulated in eosinophilic and noneosinophilic chronic.

Published byAlexina Dorsey Modified over 6 years ago

Similar presentations

Presentation on theme: "The antimicrobial protein short palate, lung, and nasal epithelium clone 1 (SPLUNC1) is differentially modulated in eosinophilic and noneosinophilic chronic."— Presentation transcript:

1 The antimicrobial protein short palate, lung, and nasal epithelium clone 1 (SPLUNC1) is differentially modulated in eosinophilic and noneosinophilic chronic rhinosinusitis with nasal polyps  Yi Wei, MD, Wentong Xia, MD, Xingling Ye, MD, Yunping Fan, PhD, Jianbo Shi, PhD, Weiping Wen, PhD, Pingchang Yang, PhD, Huabin Li, MD  Journal of Allergy and Clinical Immunology  Volume 133, Issue 2, Pages e12 (February 2014) DOI: /j.jaci Copyright © 2013 American Academy of Allergy, Asthma & Immunology Terms and Conditions

2 Fig 1 SPLUNC1 mRNA expression in nasal tissues. SPLUNC1 (A), LPLUNC2 (B), BPI (C), TLR2 (D), TLR3 (E), and TLR4 (F) mRNA levels were significantly reduced in polyp tissues from patients with CRSwNP compared with values seen in the other subgroups. Results are expressed as medians (interquartile ranges). *P < .05, **P < .01, and ***P < .001. Journal of Allergy and Clinical Immunology  , e12DOI: ( /j.jaci ) Copyright © 2013 American Academy of Allergy, Asthma & Immunology Terms and Conditions

3 Fig 2 Protein expression and distribution of SPLUNC1 in nasal tissues. Representative Western blot results (A), densitometric analysis (B), ELISA analysis (C), quantitative analysis of SPLUNC1 staining intensity (D), and representative SPLUNC1 staining (E; ×200 and ×400 magnification) in nasal tissues from patients with CRSwNP and those with CRSsNP, as well as control subjects, is shown. Data are expressed as medians (interquartile ranges). ***P < .001. Journal of Allergy and Clinical Immunology  , e12DOI: ( /j.jaci ) Copyright © 2013 American Academy of Allergy, Asthma & Immunology Terms and Conditions

4 Fig 3 SPLUNC1 mRNA and protein expression in eosinophilic (EOS) and noneosinophilic (nEOS) polyp tissues. A, mRNA expression of SPLUNC1 in polyp tissues. B-D, ELISA analysis (Fig 3, B), representative Western blot results (Fig 3, C), and densitometric analysis (Fig 3, D) of SPLUNC1 in tissue extracts of nasal polyps. ***P < .001. Journal of Allergy and Clinical Immunology  , e12DOI: ( /j.jaci ) Copyright © 2013 American Academy of Allergy, Asthma & Immunology Terms and Conditions

5 Fig 4 SPLUNC1 mRNA and protein levels in cultured PECs and A549 cells in response to TLR agonists. A, SPLUNC1 mRNA expression after a 12-hour stimulation. B, ELISA analysis of SPLUNC1 levels in supernatants after a 24-hour stimulation. C and D, Representative Western blot results of cell lysates (Fig 4, C) and densitometric analysis (Fig 4, D) after a 24-hour stimulation. Results represent mean values from 3 independent experiments. Data are expressed as means (SEMs). *P < .05, **P < .01, and ***P < PGN, Peptidoglycan; PolyI:C, polyinosinic-polycytidylic acid. Journal of Allergy and Clinical Immunology  , e12DOI: ( /j.jaci ) Copyright © 2013 American Academy of Allergy, Asthma & Immunology Terms and Conditions

6 Fig 5 SPLUNC1 mRNA expression in cultured PECs and A549 cells in response to proinflammatory cytokines. A, SPLUNC1 mRNA expression after a 12- or 24-hour stimulation. B-D, Representative Western blot results (Fig 5, B), densitometric analysis (Fig 5, C), and ELISA analysis (Fig 5, D) of SPLUNC1 levels in supernatants after a 24-hour stimulation. Results represent mean values from 3 independent experiments. Data are expressed as means (SEMs). *P < .05, **P < .01, and ***P < .001. Journal of Allergy and Clinical Immunology  , e12DOI: ( /j.jaci ) Copyright © 2013 American Academy of Allergy, Asthma & Immunology Terms and Conditions

7 Fig E1 Submucosal gland number and staining intensity in nasal tissues. A, Representative results after PAS staining (×200 magnification). B and C, Mean number (Fig E1, B) and glandular staining intensity (Fig E1, C) of submucosal glands. Results are expressed as medians (interquartile ranges). ***P < .001. Journal of Allergy and Clinical Immunology  , e12DOI: ( /j.jaci ) Copyright © 2013 American Academy of Allergy, Asthma & Immunology Terms and Conditions

8 Fig E2 SPLUNC1 expression and submucosal glandular staining in tissue from patients with eosinophilic (EOS) and noneosinophilic (nEOS) CRSwNP. A, Representative results of MBP, SPLUNC1, and PAS staining (×200 magnification). B, Number of tissue eosinophils (MBP-positive cells per high-power field [HPF], ×200 magnification). C, SPLUNC1 immunostaining intensity. D and E, Mean number (Fig E2, D) and glandular staining intensity (Fig E2, E) of submucosal glands. Data are expressed as medians (interquartile ranges). ***P < .001. Journal of Allergy and Clinical Immunology  , e12DOI: ( /j.jaci ) Copyright © 2013 American Academy of Allergy, Asthma & Immunology Terms and Conditions

9 Fig E3 Histologic profiles of tissues from patients with eosinophilic (EOS) and noneosinophilic (nEOS) CRSwNP. A, Representative results of MBP, H&E, and Masson trichrome staining (×200 magnification). B, Semiquantitative score of tissue edema. C, Percentage of area covered by collagen deposition. Data are expressed as medians (interquartile ranges). ***P < .001. Journal of Allergy and Clinical Immunology  , e12DOI: ( /j.jaci ) Copyright © 2013 American Academy of Allergy, Asthma & Immunology Terms and Conditions

10 Fig E4 Tissue distribution, as well as mRNA and protein expression, of TLR2, TLR3, and TLR4 in tissue from patients with eosinophilic (EOS) and noneosinophilic (nEOS) CRSwNP. A-C, Representative TLR immunostaining in polyp tissues (×200 magnification). D-F, mRNA expression of TLR2,TLR3, and TLR4. G-J, Representative Western blot results (Fig E4, G) and densitometric analysis (Fig E4, H-J) of TLR2, TLR3, and TLR4 protein expression. **P < .01 and ***P < .001. Journal of Allergy and Clinical Immunology  , e12DOI: ( /j.jaci ) Copyright © 2013 American Academy of Allergy, Asthma & Immunology Terms and Conditions

11 Fig E5 mRNA expression of the proinflammatory cytokines IL-4 (A), IL-13 (B), IL-1α (C), IFN-γ (D), and IL-17A (E) in eosinophilic (EOS) and noneosinophilic (nEOS) polyp tissues. Data are expressed as medians (interquartile ranges). ***P < .001. Journal of Allergy and Clinical Immunology  , e12DOI: ( /j.jaci ) Copyright © 2013 American Academy of Allergy, Asthma & Immunology Terms and Conditions

12 Fig E6 mRNA expression of SPLUNC1 in PECs in response to glucocorticoid treatment. SPLUNC1 mRNA levels were significantly upregulated after stimulation with glucocorticoid alone (A) or glucocorticoid in combination with the proinflammatory cytokines IL-4, IL-13, IFN-γ, and IL-17A (B-E). Results represent mean values from 3 independent experiments. Data are expressed as means (SEMs). Bud, Budesonide; Dex, dexamethasone; Flu, fluticasone. *P < .05, **P < .01, and ***P < .001. Journal of Allergy and Clinical Immunology  , e12DOI: ( /j.jaci ) Copyright © 2013 American Academy of Allergy, Asthma & Immunology Terms and Conditions

13 Fig E7 Protein levels of SPLUNC1 in nasal secretions from patients with CRSwNP. Increased SPLUNC1 in nasal secretions (A) and improved total nasal symptom scores (visual analog scale [VAS] score); (B) before and after patients received glucocorticoid treatment. Solid bars represent median values. ***P < .01. Journal of Allergy and Clinical Immunology  , e12DOI: ( /j.jaci ) Copyright © 2013 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Download ppt "The antimicrobial protein short palate, lung, and nasal epithelium clone 1 (SPLUNC1) is differentially modulated in eosinophilic and noneosinophilic chronic."

Similar presentations

Maria B. Sukkar, PhD, Shaoping Xie, PhD, Nadia M

Maria B. Sukkar, PhD, Shaoping Xie, PhD, Nadia M
Proton pump inhibitors decrease eotaxin-3/CCL26 expression in patients with chronic rhinosinusitis with nasal polyps: Possible role of the nongastric.

Proton pump inhibitors decrease eotaxin-3/CCL26 expression in patients with chronic rhinosinusitis with nasal polyps: Possible role of the nongastric.
Anju T. Peters, MD, Atsushi Kato, PhD, Ning Zhang, PhD, David B

Anju T. Peters, MD, Atsushi Kato, PhD, Ning Zhang, PhD, David B
Intraepithelial neutrophils in pediatric severe asthma are associated with better lung function  Cecilia K. Andersson, PhD, Alexandra Adams, MBBS, Prasad.

Intraepithelial neutrophils in pediatric severe asthma are associated with better lung function  Cecilia K. Andersson, PhD, Alexandra Adams, MBBS, Prasad.
Forkhead box protein 3 in human nasal polyp regulatory T cells is regulated by the protein suppressor of cytokine signaling 3  Feng Lan, MD, Nan Zhang,

Forkhead box protein 3 in human nasal polyp regulatory T cells is regulated by the protein suppressor of cytokine signaling 3  Feng Lan, MD, Nan Zhang,
Critical link between glycogen synthase kinase 3β and forkhead box P3 in patients with chronic rhinosinusitis with nasal polyps  Xingmei Wu, MD, Sihua.

Critical link between glycogen synthase kinase 3β and forkhead box P3 in patients with chronic rhinosinusitis with nasal polyps  Xingmei Wu, MD, Sihua.
Russell S. Traister, MD, PhD, Crystal E. Uvalle, BS, Gregory A

Russell S. Traister, MD, PhD, Crystal E. Uvalle, BS, Gregory A
Forkhead box protein 3 in human nasal polyp regulatory T cells is regulated by the protein suppressor of cytokine signaling 3  Feng Lan, MD, Nan Zhang,

Forkhead box protein 3 in human nasal polyp regulatory T cells is regulated by the protein suppressor of cytokine signaling 3  Feng Lan, MD, Nan Zhang,
Proton pump inhibitors decrease eotaxin-3/CCL26 expression in patients with chronic rhinosinusitis with nasal polyps: Possible role of the nongastric.

Proton pump inhibitors decrease eotaxin-3/CCL26 expression in patients with chronic rhinosinusitis with nasal polyps: Possible role of the nongastric.
Heterogeneous inflammatory patterns in chronic rhinosinusitis without nasal polyps in Chicago, Illinois  Bruce K. Tan, MD, MS, Aiko I. Klingler, PhD,

Heterogeneous inflammatory patterns in chronic rhinosinusitis without nasal polyps in Chicago, Illinois  Bruce K. Tan, MD, MS, Aiko I. Klingler, PhD,
Impaired TH17 responses in patients with chronic mucocutaneous candidiasis with and without autoimmune polyendocrinopathy–candidiasis–ectodermal dystrophy 

Impaired TH17 responses in patients with chronic mucocutaneous candidiasis with and without autoimmune polyendocrinopathy–candidiasis–ectodermal dystrophy 
IL-25 as a novel therapeutic target in nasal polyps of patients with chronic rhinosinusitis  Hyun-Woo Shin, MD, PhD, Dong-Kyu Kim, MD, Min-Hyun Park, MD,

IL-25 as a novel therapeutic target in nasal polyps of patients with chronic rhinosinusitis  Hyun-Woo Shin, MD, PhD, Dong-Kyu Kim, MD, Min-Hyun Park, MD,
Anju T. Peters, MD, Atsushi Kato, PhD, Ning Zhang, PhD, David B

Anju T. Peters, MD, Atsushi Kato, PhD, Ning Zhang, PhD, David B
Distinct immunopathologic characteristics of various types of chronic rhinosinusitis in adult Chinese  Ping-Ping Cao, MD, Hua-Bin Li, MD, PhD, Bao-Feng.

Distinct immunopathologic characteristics of various types of chronic rhinosinusitis in adult Chinese  Ping-Ping Cao, MD, Hua-Bin Li, MD, PhD, Bao-Feng.
Extracellular eosinophilic traps in association with Staphylococcus aureus at the site of epithelial barrier defects in patients with severe airway inflammation 

Extracellular eosinophilic traps in association with Staphylococcus aureus at the site of epithelial barrier defects in patients with severe airway inflammation 
Intraepithelial neutrophils in pediatric severe asthma are associated with better lung function  Cecilia K. Andersson, PhD, Alexandra Adams, MBBS, Prasad.

Intraepithelial neutrophils in pediatric severe asthma are associated with better lung function  Cecilia K. Andersson, PhD, Alexandra Adams, MBBS, Prasad.
Frank Kirstein, PhD, Natalie E

Frank Kirstein, PhD, Natalie E
Julie M. Caldwell, PhD, Carine Blanchard, PhD, Margaret H

Julie M. Caldwell, PhD, Carine Blanchard, PhD, Margaret H
FcεRI-mediated amphiregulin production by human mast cells increases mucin gene expression in epithelial cells  Shigeru Okumura, DDS, PhD, Hironori Sagara,

FcεRI-mediated amphiregulin production by human mast cells increases mucin gene expression in epithelial cells  Shigeru Okumura, DDS, PhD, Hironori Sagara,
Chronic rhinosinusitis with polyps and without polyps is associated with increased expression of suppressors of cytokine signaling 1 and 3  Se Jin Park,

Chronic rhinosinusitis with polyps and without polyps is associated with increased expression of suppressors of cytokine signaling 1 and 3  Se Jin Park,

Similar presentations

Ads by Google